Clinical relevance of miRNAs as biomarkers is growing due to their stability and detection in biofluids. This study has identified miR-519a-3p as a potential early biomarker for Alzheimer’s, linked to prion protein expression. This molecule is directly associated with the expression of the cellular prion protein located on the surface of nerve cells. miR-519a-3p may potentially be used as a biomarker of preclinical stages of the disease.

https://www.sciencedirect.com/science/article/pii/S0925443924001765?via%3Dihub (open access)

  • originalucifer
    link
    fedilink
    1617 days ago

    In our study, we compared the levels of this biomarker in samples from other tauopathies and Parkinson’s disease, confirming that the changes in miR-519a-3p are specific to Alzheimer’s disease,” said IBEC senior researcher Rosalina Gavín, UB associate professor and co-leader of the study.

    coooool!

  • @just_another_person@lemmy.world
    link
    fedilink
    16
    edit-2
    17 days ago

    This is important because because it’s easily measurable, comparable, and likely to be unique. This was not the case with the Amyloid Plaque route of research (recently announced to be retracted due to falsified imaging in the original studies) where it could exist in non-Alzheimer patients in similarly measurable quantities. Takes a lot of the guesswork out.

    Science fucking rules.

    • @PhlubbaDubba@lemm.ee
      link
      fedilink
      816 days ago

      Why in the fuck would you falsify data in something this important? People are gonna find you out instantly when they try your shit and nothing changes.

        • @asdfasdfasdf@lemmy.world
          link
          fedilink
          1
          edit-2
          14 days ago

          I’d think any sane society, business, or institution would blacklist him / remove any certifications he has, sue him, and possibly other courses of legal action like fraud.